As new concepts for drug discovery in the post-genomic age continue to be introduced, synthetic organic chemistry continues to be pivotal to the success of these programs. Adesis, Inc. is a contract research organization (CRO) specializing in organic synthesis.
We specialize in the synthesis of milligrams to kilogram quantities including:
- Early stage proof-of-concept (POP) projects to validate biological hypotheses
- Validation of screening hits for exploratory medicinal chemistry (hit-to-lead)
- In-depth structure-activity relationship (SAR) studies
- Intermediates for expediting med chemistry SAR campaigns
- Drug candidates for in vivo studies
- Reference agents for bioprofiling
- Reference metabolites
- Building blocks for combinatorial chemistry
- Key intermediates for pharmaceuticals
- Key intermediates for biomaterial and biosensor applications